The startup operates a biotechnology platform that utilizes artificial intelligence and big data to develop point-of-care diagnostics for Trichomonas vaginalis, the most prevalent non-viral sexually transmitted infection. By providing a repository of monoclonal antibodies, the company enables researchers to identify novel therapeutic targets and biomarkers, enhancing STI prevention efforts.
Funding
Funding not disclosed
Founders
Product
Problem
_Trichomonas vaginalis_ is the most prevalent non-viral sexually transmitted infection worldwide, yet effective point-of-care diagnostics and targeted therapies are lacking. Researchers need better tools to identify novel therapeutic targets and biomarkers for enhanced STI prevention.
Solution
The company provides a biotechnology platform that leverages a comprehensive repository of monoclonal antibodies for _Trichomonas vaginalis_. This resource enables researchers to develop improved point-of-care diagnostics and identify novel therapeutic targets. The platform offers access to a diverse inventory of monoclonal antibodies, facilitating the discovery of biomarkers and the development of targeted interventions for STI prevention. By providing these critical research tools, the company aims to advance the understanding and management of _Trichomonas vaginalis_ infections.
Target Audience
The primary audience includes researchers, diagnostic companies, and pharmaceutical organizations focused on developing solutions for sexually transmitted infections, particularly _Trichomonas vaginalis_.
Features
- Extensive inventory of monoclonal antibodies specific to _Trichomonas vaginalis_
- Novel monoclonal antibodies targeting AEG::SOE3 (49.41-kDA) chimeric protein
- Novel monoclonal antibodies targeting AEG::SOE2 (40-kDA) chimeric protein
- Monoclonal antibody (14F12 at 61-kDa) recognizing phosphoglucomutase and phosphomannomutase proteins
- Monoclonal antibody (CF130C3 at 21.5-kDa) recognizing RNA-binding protein RBP1
- Antibodies available for licensing and research collaborations